title: Effect of recombinant human growth hormone on urinary 15N-nitrogen balance in girls with Turner syndrome as compared to children with growth hormone deficiency.
abstract: 15N-nitrogen balances before and on human growth hormone (hGH) were studied in 13 girls with Turner syndrome (TS) aged 4.4-16 (median 13.2) years (45,X0 or equivalent, no X0/XX mosaicism, no estrogen replacement). The results were compared with those reported from 9 patients with growth hormone deficiency (GHD). The TS patients received subcutaneous hGH doses of 2 x 3 (group A, n = 6), 3 x 2 (group B, n = 3), or 2 x 6 (group C, n = 4) IU/m2 on consecutive days. The mean 15N dose given to the patients of groups A and C was higher (13.6 mg/kg) than that given to those of group B (2.7 mg/kg). The lower hGH doses in the first two groups induced small positive mean 15N balance changes (+0.6 +/- 0.6 mg/kg 15N, group A; +0.03 mg/kg, group B). The higher hGH dose in group C caused a more marked mean balance change (+3.0 mg/kg 15N) comparable to that in GHD patients (+3.2 mg/kg). Individual variation of response, however, was larger in patients with TS than in those with GHD. With low and high hGH doses, there were responders and nonresponders. It is concluded from this pilot study in a small number of cases that 15N balance studies might be potentially useful to choose the appropriate hGH dose for long-term treatment in TS patients.
authors.affiliation: Department of Pediatrics, University of Zürich, Switzerland.
authors.forename: K
authors.initials: K
authors.lastname: Rother
authors.forename: M
authors.initials: M
authors.lastname: Zachmann
authors.forename: B
authors.initials: B
authors.lastname: Kempken
authors.forename: A
authors.initials: A
authors.lastname: Grüters
authors.forename: D
authors.initials: D
authors.lastname: Schnabel
authors.forename: D
authors.initials: D
authors.lastname: L'Allemand
authors.forename: G
authors.initials: G
authors.lastname: Häusler
authors.forename: H
authors.initials: H
authors.lastname: Frisch
mesh_terms: D000293:Adolescent; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage* / Q000172:deficiency / Q000627:therapeutic use; D006801:Humans; D009584:Nitrogen / Q000652:urine*; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D014424:Turner Syndrome / Q000188:drug therapy* / Q000652:urine
chemical_list: D011994:Recombinant Proteins; D013006:Growth Hormone; D009584:Nitrogen